About
Who We Are
BioCelerate is a subsidiary of TransCelerate and operates with separate funding and support. It brings biopharmaceutical companies together to work on shared scientific challenges that can help improve how new medicines are developed. BioCelerate initiatives are guided by a Governing Council made up of participating companies. TransCelerate and BioCelerate are led by CEO Janice Chang.
BioCelerate membership requires membership in TransCelerate and is open to organizations engaged in the discovery, development, and manufacturing of new medicines. Information about membership is available on the TransCelerate website.
Our Member Companies
BioCelerate’s founding Member Companies are Bristol-Myers Squibb, Eli Lilly & Company, Novo, and Shionogi. Members of BioCelerate must be members of TransCelerate. Information about membership and a membership application is available on the TransCelerate website.
